Ledger.Open graph →
SEC Form D · Amendment · filed April 18, 2017

Gila Therapeutics, Inc

Offering
$4.0M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minneapolis, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Sergei J. Zolutukhin · Minneapolis, MNPromoterJon J. Freeman · Minneapolis, MNExecThomas J. Vasicek · Minneapolis, MNExec · Director · PromoterChristopher J. Desouza · Minneapolis, MNDirectorRichard J. Horan · Minneapolis, MNDirectorAndres J. Acosta · Minneapolis, MNPromoterRichard J. Horan · Minneapolis, MNDirectorRobert K. Lewis · Austin, TXExec · Director · PromoterRaul C. Romero · Austin, TXPromoterDavid Mc Geough · Killiney, Dublin, IrelandExecBenneth C. Cachila · Austin, TXDirectorLarry Perdido · Austin, TXPromoterGordon G. Repp · Chicago, ILDirectorDemetri G. Rackos · Chicago, ILExecJoseph K. Munoz · Chicago, ILPromoterTy G. Spearing · Chicago, ILDirectorRobert K. Hagan · Chicago, ILExec · Director · PromoterRobert B. Crumpton, Iii · Birmingham, ALPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗